CompletedNot applicableNCT00427336

Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia

Studying Aplastic Anemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
M.D. Anderson Cancer Center
Principal Investigator
Paolo Anderlini, MD
M.D. Anderson Cancer Center
Intervention
Fludarabine(drug)
Enrollment
9 enrolled
Eligibility
70 years · All sexes
Timeline
20002009

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00427336 on ClinicalTrials.gov

Other trials for Aplastic Anemia

Additional recruiting or active studies for the same condition.

See all trials for Aplastic Anemia

← Back to all trials